Preferred Maximum Strength Urinary Pain Relief
- Product NDC
- 10956-333
- 11-digit product format
- 109560333
- Labeler code
- 10956
- Product ID
- 10956-333_774c416e-1b8b-424c-ac0d-39ae52934a42
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- PHENAZOPYRIDINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Reese Pharmaceutical Co
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2015-01-15
- Marketing end
- 0000-00-00
- Substance
- PHENAZOPYRIDINE HYDROCHLORIDE
- Active strength
- 98 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 10956-333 | | I | Inactivated by FDA | | 2026-07-31 |
| excluded package | package | 10956-333 | 10956-333-12 | I | Inactivated by FDA | | 2026-07-31 |
| excluded package | package | 10956-333 | 10956-333-24 | I | Inactivated by FDA | | 2026-07-31 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10956-333 | PREFERRED MAXIMUM STRENGTH URINARY PAIN RELIEF (PHENAZOPYRIDINE HYDROCHLORIDE) TABLET [REESE PHARMACEUTICAL CO] | 2 | Legacy NDC | 20190208_40ed6506-5847-497f-b0ff-7c43acfbe006.zip |
DailyMed RxNorm Mappings#